We further demonstrated that cell apoptosis, induced by IDO2 downregulation, can be attenuated by addition of exogenous NAD+, suggesting a novel mechanism by which IDO2 promotes tumor growth through its metabolite product NAD+. Here, IDO2 is linked to neoplasm.